rethinkTHC Search
Menu
Study breakdown

Cannabis in cancer care: what works, what might work, and what we don't know yet

ReviewModerate evidence
The takeaway

There is sufficient evidence that cannabis helps with cancer-related symptoms like nausea, pain, and insomnia, but antitumor effects shown in preclinical studies have not yet been confirmed in humans.

Cancer patients, oncologists, and anyone interested in cannabis and cancer research.

Palliative use supported; antitumor effects unproven in humans

What the researchers found

Sufficient evidence supports cannabis for palliative indications in oncology, including chemotherapy-induced nausea and vomiting, cancer-related pain, anorexia, insomnia, and anxiety. Preclinical data show potent antineoplastic (antitumor) activity through immunological and direct mechanisms. However, no clinical trials have confirmed antitumor effects in humans. Concepts like synergism with conventional treatments, dosing sequence, and molecular cross-talk remain largely unexplored.

Why it matters

Cancer patients are among the most common medical cannabis users, but there is a large gap between what preclinical research suggests about antitumor effects and what has been proven in humans.

The numbers in context

No specific pooled statistics. Review covered both natural and synthetic cannabinoids across palliative and potential antitumor applications.

How the study worked

Narrative review classifying cannabinoids by natural and synthetic subtypes, examining mechanisms of action, clinical evidence for palliative indications, and preclinical evidence for antitumor activity.

What this study cannot tell us

Narrative review. No meta-analysis of palliative outcomes. Antitumor evidence is entirely preclinical. Regulatory barriers limit clinical trial design and conduct.

How to read the evidence

Strong evidence base for symptom management; preclinical-only evidence for antitumor claims.

When this study was published

2019 review.

The bigger picture

The palliative evidence is solid enough to guide clinical decisions, but the more exciting antitumor potential remains in early stages. The danger is that patients may rely on cannabis instead of proven treatments based on premature conclusions.

Questions still open

  • Will the antitumor effects seen in lab studies translate to humans? Could cannabis interact with chemotherapy or immunotherapy in harmful ways?

Common questions

Does cannabis help cancer patients?
Evidence supports cannabis for managing cancer-related symptoms including nausea from chemotherapy, pain, poor appetite, insomnia, and anxiety.
Can cannabis cure cancer?
Lab studies show cannabinoids can kill cancer cells and inhibit tumor growth, but these effects have not been confirmed in human clinical trials. No evidence currently supports cannabis as a cancer treatment.

Read the original research

Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology.

Expert opinion on investigational drugs, 28(3), 285-296

Citation

Turgeman, Ilit; Bar-Sela, Gil. (2019). Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology.. Expert opinion on investigational drugs, 28(3), 285-296. https://doi.org/10.1080/13543784.2019.1561859

Explore the wider topic